Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-10-29

FDA Approved: HALOPERIDOL — Supplemental Application (Sagent Pharmaceuticals)

View source ↗

Summary

FDA approved a supplemental application for HALOPERIDOL LACTATE by Sagent Pharmaceuticals under anANDA, indicating an approved supplemental action to the drug's…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HALOPERIDOL LACTATE (HALOPERIDOL)

Snippet

SUPPL AP for HALOPERIDOL (HALOPERIDOL LACTATE)